Foley Senior Counsel Nathaniel Lacktman was quoted in an article that appeared in the Tampa Bay Business Journal on January 28, 2011 titled "Clinical trials seen as driving economic sector; M2Gen's presence helping." Lacktman discusses the efforts of M2Gen, the for-profit subsidiary of Moffitt Cancer Center, to help position the Tampa Bay region as a national leader in drug development. He states that M2Gen's work should draw drug developers, physicians and other service providers to the area.